Irwin Naturals Continues To Expand Clinic Footprint
June 21, 2022
Ryan Allway June 21st, 2022 News, Psychedelics, Top News LOS ANGELES, June 21, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) will add to its rapidly growing chain of psychedelic mental health centers, announcing today that it has signed a definitive agreement... Read more
Ryan Allway May 4th, 2022 Psychedelics, Top News Generated record gross revenues of $5.6 million in 2021, representing 124% growth YOY Maintained a strong capital position with $28.8 million of assets, and $6.4 million of liabilities LANGLEY, BC, May 4, 2022 /CNW/ – Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (“Adastra” or the “Company”) is pleased to... Read more
Wake Network, Inc. and the Lieber Institute for Brain Development Announce Research Collaboration
July 21, 2021
Ryan Allway July 21st, 2021 Psychedelics July 21, 2021 – Wake Network, Inc., a global leader in psilocybin mushroom research, production and the developer of genomics-based integration therapies, is pleased to announce a collaboration with the Lieber Institute for Brain Development (the ” Lieber Institute “), a non-profit research Institution... Read more
Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange
May 28, 2021
Ryan Allway May 28th, 2021 Psychedelics TORONTO, May 27, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip“), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares... Read more
Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
April 21, 2021
Ryan Allway April 21st, 2021 Psychedelics VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (”Core One”) a life sciences research and technology company focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic-assisted psychotherapy is... Read more
Psychedelics: Investing in the Perfect BrainStorm
April 3, 2020
Ryan Allway April 3rd, 2020 App, Exclusive, News, Top Story Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space. In this article, we will take a look at the growing... Read more
5 Ways to Participate in the Psychedelics Boom
March 27, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Psychedelics, the Next Frontier in Drug Research
February 28, 2020
Ryan Allway February 28th, 2020 App, Exclusive, News, Top Story A big factor in the recent rise of cannabis legalization is the emergence of legitimate scientific research into the potential health benefits of the plant’s active ingredients, called cannabinoids. Medicines are often derived from naturally occurring compounds, from aspirin... Read more
